Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model.

MLA

Jinil Kim, et al. “Evaluation of Drug Mechanism and Efficacy of a Novel Anti-Angiogenic Agent, TTAC-0001, Using Multi-Modality Bioimaging in a Mouse Breast Cancer Orthotopic Model.” PLoS ONE, vol. 13, no. 1, Jan. 2018, p. e0187063. EBSCOhost, https://doi.org/10.1371/journal.pone.0187063.

APA

Jinil Kim, Sang Hyun Choi, Su Jung Ham, Young Chul Cho, Seul-I Lee, Jeeheon Kang, Dong-Cheol Woo, Weon Sub Lee, Jin-San Yoo, Kyung Won Kim, & Yoonseok Choi. (2018). Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model. PLoS ONE, 13(1), e0187063. https://doi.org/10.1371/journal.pone.0187063

Chicago

Jinil Kim, Sang Hyun Choi, Su Jung Ham, Young Chul Cho, Seul-I Lee, Jeeheon Kang, Dong-Cheol Woo, et al. 2018. “Evaluation of Drug Mechanism and Efficacy of a Novel Anti-Angiogenic Agent, TTAC-0001, Using Multi-Modality Bioimaging in a Mouse Breast Cancer Orthotopic Model.” PLoS ONE 13 (1): e0187063. doi:10.1371/journal.pone.0187063.